OMO (Original Manufacturing Operation)

OMO, Short for original manufacturing operation, which is service term for our customers that have their own registered drug and branding in their destination countries.

During OMO operation, we provide our customers the finished products, half-finished products and also bulk materials (if possible). It is very effective for accredit customers who have their products licenses in their own region and have the need that their own brand should be used in process of marketing the products.

Normally, Kelun Bio-Pharam's or kelun's contractual manufacturer's name as the manufacturer should be remained on the statement (packaging and insert) and drug should be registered in the designed region during OMO. Kelun is the original manufacture and has the responsibility to the products, including warranty and etc.

Certain products are not permitted to be reselled in terms of bulk or raw material form, e.g. plasma products and vaccines, please check the policy and standard page for details.

 

 

 


China's direct
China's direct outbound investment will exceed 60 billion U.S. dollars by 2010, said Assistant Minister of Commerce Chen Jian here on Monday.

·

China Lacks Plasma Source
SFDA is revising Medical Apparatus and Instrument Control.

·

Sino-US Research Center for Clinical Drugs Founded


Copyright & Legal Disclaimer | Privacy Policy                         © Kelun Bio-Pharma